165 research outputs found

    The effectiveness of ultrasonogram guided intervention in chronic shoulder pain cases attending pain clinic of a government hospital of East zone, India: a prospective observational study

    Get PDF
    Background: Ultrasonogram guided intervention in chronic shoulder pain is well known for relief of pain and improvement of range of movement (ROM) of affected shoulder joint. Ultrasonogram gives accuracy helps in localized corticosteroid delivery. Corticosteroids relieve the pain by its anti-inflammatory effect. There is conflicting evidence available regarding the effectiveness of the intervention in chronic shoulder pain, questioned in many studies. We planned this study to evaluate the efficacy of ultrasonogram guided intervention in chronic shoulder pain in a tertiary teaching hospital of rural Bengal.Methods: The prospective observational study was carried out in 100 patients with chronic shoulder pain attending pain clinic who fulfilled predetermined inclusion criteria. Patients were injected with 40 mg of depomethyl prednisolone and 10 ml of 1% preservative free lignocaine via standard posterior approach. Then half an hour of standard shoulder range of motion (ROM) exercise regimen was performed under supervision. Pre injection and post injection pain level were scored by visual analogue score (VAS) shoulder exercises were taught and home-based physiotherapy was carried out by patients themselves. Patient were followed at 4, 8, and 12 weeks.Results: The mean age of patients was 53.23±5.680 years with 63 % male study subjects, After the intervention, excellent result in VAS score and improvement of ROM observed in patients. There was statistically significant difference from baseline in both pain relief and shoulder movement.Conclusions: USG guided intervention is effective in pain relief and in improvement in ROM in chronic shoulder pain in long term

    Pharmaceutical application of solid dispersion technology in improving solubility of poorly soluble drugd : a review

    Get PDF
    Together with the permeability, the solubility of a drug plays an important role in determining its oral bioavailability. Nowadays, a majority of the new chemical entities are poorly water soluble candidates. For formulation scientists, it is a big deal to handle those drug candidates in order to formulate a stable pharmaceutical dosage form with appropriate bioavailability. To increase the oral bioavailability of poorly soluble drugs, so far formulation scientists have adopted many chemical and formulation approaches. Out of those approaches, solid dispersion has played an important role for the past few decades. There are many formulation strategies employed to prepare solid dispersions. Solid dispersion mainly increases solubility and dissolution characteristics and thereby also oral bioavailability of poorly soluble drugs. The present review article deals with different strategies of solid dispersion preparation techniques, problems associated with those techniques and how to overcome them in order to improve the solubility as well as bioavailability ofpoorly water soluble drugs

    Nano transfersomes vesicles of raloxifene HCl with sorbitan 80: formulation and characterization

    Get PDF
    Lipid vesicles in the nano range with ionic and nonionic surfactants are known as transfersomes. The presence of surfactant in the bilayer structure makes the vesicles very flexible in nature and helps them to permeate through the stratum corneum. The purpose of this research was to develop and characterize a transfersomal formulation of raloxifene HCl to deliver it into systemic circulation through the transdermal route. The transfersomal formulation was prepared by the rotary evaporation method with phospholipon 90G and sorbitan 80. The particle size, zeta potential and polydispersity index (PDI) of the formulation were measured. The drug entrapment efficiency (EE%) of the vesicles was determined by an indirect ultracentrifugation method. Differential scanning calorimetry (DSC), ex-vivo skin permeation study, field emission scanning electron microscope (FESEM), high resolution transmission electron microscope (HRTEM) and confocal laser scanning microscopy (CLSM) study were carried out as parts of advanced characterization of the developed formulation. The vesicles were found to have an average particle size of 95.1±1.05nm with a PDI value of 0.162±0.01 and zeta potential of +17.62±0.29 mV. EE% was recorded up to 90.9±1.15. Transdermal flux (J = 4.66±0.79 μg/cm2hr) of the developed formulation showed a favorable value required for the formulation efficacy. FESEM and TEM study results proved the spherical and round structures of the vesicles. DSC showed that the raloxifene was in the non-crystal form and was enclosed in the lipid bilayer. CLSM study proved the distribution of the drug in the stratum corneum, viable epidermis and dermis with high fluorescence intensity. The developed nano transfersomes of raloxifene HCl with sorbitan 80 showed encouraging results and can be further investigated for in vivo efficacy

    DEVELOPMENT AND VALIDATION OF A SIMPLE HPLC METHOD FOR ESTIMATION OF MYCOPHENOLATE MOFETIL IN MICROEMULSION FORMULATION

    Get PDF
    Objective: The present study deals with the development, validation and application of a simple, precise and accurate HPLC method for the determination of mycophenolate mofetil in pharmaceutical formulations and microemulsions. Methods: In this method, a simple isocratic mobile phase composition of methanol and water (75:25 v/v) pumped at 1 ml/minute flow rate through Phenomenex C18 column (dimension: 250 4.6 mm and 5 µm particle size) was used. Injection volume was 20 µl and analysis of mycophenolate mofetil was carried out at 250 nm. Results: The coefficient of regression was found to be 0.9996, indicating the linearity of the developed method within a range of 0.1 to 10 µg/ml. The limit of detection (LOD) and the limit of quantization (LOQ) were found to be 3.660ng/ml and 11.091ng/ml, respectively. The results showed that % deviation for change in compositions of the mobile phase, flow rate and temperature was within a range of-5.51 to 10.99%,-3.70 to 8.80% and-5.29 to 10.90%, respectively. The method seemed sensitive to change of temperature (±5 ○C) and methanol composition (±2%) as the results were at the boundary limit of 10% deviation. Conclusion: A simple, precise and accurate HPLC method for the determination of drug content from microemulsion has been developed and validated in accordance with ICH guidelines

    Formulation and optimization of raloxifene loaded nanotransfersomes by response surface methodology for transdermal drug delivery

    Get PDF
    Raloxifene HCl loaded transfersomes were fabricated, optimized, and characterized as carrier for transdermal delivery to overcome the poor bioavailabilty issue with the drug. Response surface methodology (RSM) was applied for optimization of the formulation with Box-Behnken experimental design. Phospholipid PC90G (A), sodium deoxycholate (SDC) (B) and sonication time (C), each at three levels, were selected as independent variables while entrapment efficiency (EE%) (Y1), vesicle size (Y2), and transdermal flux (Y3) were the response variables. The optimized formulation was further characterized for vesicular size distribution, shape, surface morphology, and zeta-potential. Response variables data were analyzed by Design expert® software and the best model for all three response variables was found to be quadratic. Formulation No13 with composition of 300mg PC90G (A), 35mg SDC (B) and 15min sonication time (C) was predicted as the optimized formulation. The optimized formulation resulted a particle size of 134±9.0 nm with 91±4.9% EE%, 6.5±1.1μg/cm2/h transdermal flux, and -2.61±0.5 mV zeta potential. Transmission electron microscopy, scanning electron microscopy, and dynamic light scattering study defined transfersomes as spherical,unilamellar structures with a homogenous distribution and low polydispersity index (0.080±0.021). Transfersomal formulation proved significantly superior in terms of amount of drug permeated and deposited in the skin, with an enhancement ratio of 6.25±1.5 and 9.25±2.4 when compared with conventional liposomes and ethanolic phosphate buffer solution of the drug respectively. Confocal scanning laser microscopy proved an enhanced permeation of coumarin-6 loaded transfersomes to the deeper layers of the skin (160 μm) as compared to the rigid liposomes (60 μm). These in-vitro findings proved that raloxifene HCl loaded transfersomal formulation could be a superior alternative to oral delivery of the drug

    A REVIEW ON CO-PROCESSED EXCIPIENTS: CURRENT AND FUTURE TREND OF EXCIPIENT TECHNOLOGY

    Get PDF
    There is no single-component excipient fulfills all the requisite performance to allow an active pharmaceutical ingredient to be formulated into a specific dosage form. Co-processed excipient has received much more attention in the formulation development of various dosage forms, specially for tablet preparation by direct compression method. The objective of this review is to discuss the emergence of co-processed excipients as a current and future trend of excipient technology in pharmaceutical manufacturing. Co-processing is a novel concept of combining two or more excipients that possess specific advantages that cannot be achieved using a physical admixture of the same combination of excipients. This review article discusses the advantages of co-processing, the need of co-processed excipient, general steps in developing co-processed excipient, limitation of co-processed excipient, technologies used in developing co-processing excipients, co-processed excipients in the literature, marketed products and future trends. With advantages offered by the upcoming newer combination of excipients and newer methods of co-processing, co-processed excipients are for sure going to gain attraction both from academia and pharmaceutical industry. Furthermore, it opens the opportunity for development and use of single multifunctional excipient rather than multiple excipients in the formulation

    Crystal Structure and Solid-State Properties of Metal Complexes of the Schiff Base Ligands Derived from Diacetylmonoxime: A Brief Review

    Get PDF
    The fabulous advancement of a large section of modern coordination chemistry depends upon different kinds of strategically designed and functionally tuned ligand systems; Schiff base ligands play a pivotal role among them. Such Schiff bases become more motivating when they are designed to be synthesized using very simple organic molecules. This paper reviews our work on a family of three functionally different types of Schiff base ligands, derived from diacetylmonoxime, which have been employed to synthesize mononuclear metal complexes with various binding modes of ligands and topologies around the metal centers. Such Schiff base ligands have been synthesized by reacting diacetylmonoxime with diethylenetriamine, 1,3-diaminopropane-2-ol, and morpholine N-thiohydrazide. The synthesized Schiff bases and the metal complexes of such “privileged ligands” show many interesting supramolecular coordination architectures involving different weak forces, e.g., H-bonding, C–H···π interactions, etc

    Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application

    Get PDF
    Raloxifene hydrochloride, a highly effective drug for the treatment of invasive breast cancer and osteoporosis in post-menopausal women, shows poor oral bioavailability of 2%. The aim of this study was to develop, statistically optimize, and characterize raloxifene hydrochloride-loaded transfersomes for transdermal delivery, in order to overcome the poor bioavailability issue with the drug. A response surface methodology experimental design was applied for the optimization of transfersomes, using Box-Behnken experimental design. Phospholipon ® 90G, sodium deoxycholate, and sonication time, each at three levels, were selected as independent variables, while entrapment efficiency, vesicle size, and transdermal flux were identified as dependent variables. The formulation was characterized by surface morphology and shape, particle size, and zeta potential. Ex vivo transdermal flux was determined using a Hanson diffusion cell assembly, with rat skin as a barrier medium. Transfersomes from the optimized formulation were found to have spherical, unilamellar structures, with a homogeneous distribution and low polydispersity index (0.08). They had a particle size of 13
    corecore